Education
About Us
Working with TipRanks
Follow Us
Rafael Holdings Inc (RFL)
NYSE:RFL
RFL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.29 - $2.50
Previous CloseN/A
Volume21.81K
Average Volume (3M)32.17K
Market Cap
$55.12M
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Jun 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.11
Shares Outstanding31,257,837
10 Day Avg. Volume52,433
30 Day Avg. Volume32,174
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)65.63
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Rafael Holdings News
PremiumCompany Announcements
Rafael Holdings Completes Merger with Cyclo Therapeutics
PremiumCompany Announcements
Rafael Holdings Reports Q2 Fiscal 2025 Results
PremiumCompany Announcements
Rafael Holdings: Strategic Developments and Financial Insights
PremiumCompany Announcements
Rafael Holdings Announces Strategic Merger with Cyclo Therapeutics
PremiumCompany Announcements
Rafael Holdings Appoints Oncologist Mark Stein to Board
---
Ownership Overview
24.14% Insiders
4.67% Mutual Funds
2.37% Other Institutional Investors
65.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RFL FAQ
What was Rafael Holdings Inc’s price range in the past 12 months?
Rafael Holdings Inc lowest stock price was $1.29 and its highest was $2.50 in the past 12 months.
What is Rafael Holdings Inc’s market cap?
Rafael Holdings Inc’s market cap is $55.12M.
When is Rafael Holdings Inc’s upcoming earnings report date?
Rafael Holdings Inc’s upcoming earnings report date is Jun 17, 2025 which is in 70 days.
How were Rafael Holdings Inc’s earnings last quarter?
Rafael Holdings Inc released its earnings results on Mar 13, 2025. The company reported -$0.192 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.192.
Is Rafael Holdings Inc overvalued?
According to Wall Street analysts Rafael Holdings Inc’s price is currently Overvalued.
Does Rafael Holdings Inc pay dividends?
Rafael Holdings Inc does not currently pay dividends.
What is Rafael Holdings Inc’s EPS estimate?
Rafael Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rafael Holdings Inc have?
Rafael Holdings Inc has 31,257,837 shares outstanding.
What happened to Rafael Holdings Inc’s price movement after its last earnings report?
Rafael Holdings Inc reported an EPS of -$0.192 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.667%.
Which hedge fund is a major shareholder of Rafael Holdings Inc?
Currently, no hedge funds are holding shares in RFL
---
Rafael Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 100.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.15%
12-Months-Change
Fundamentals
Return on Equity
-57.90%
Trailing 12-Months
Asset Growth
-21.77%
Trailing 12-Months
Company Description
Rafael Holdings Inc
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
---
Technical Analysis
Comstock Mining
―
Manhattan Bridge Capital
―
Clipper Realty
―
Sachem Capital
―
Global Self Storage
―
---